About Bayou Vantage
Bayou Vantage exists because regulated organizations rarely fail because the technology is wrong. They fail because no one translated the operational, compliance, and inspection consequences into a system the quality organization could actually own and defend.
Keisha Daniels built this firm on 20+ years of direct experience inside pharmaceutical and biologics manufacturing, quality systems, and compliance operations. The perspective is not theoretical. It comes from the work itself.
B.S., Chemistry — Dillard University · Certified Quality Auditor (CQA), ASQ · AI & Machine Learning Certification, Emory University (in progress) · AI Consultant Certification (in progress)
Founder perspective
Bayou Vantage was built from operating exposure, not borrowed language. The advisory model is intentionally senior, specific, and grounded in what regulated organizations must defend when the scrutiny becomes real.
Clients do not hire a generic transformation partner. They hire judgment shaped by manufacturing consequence, documentation pressure, platform complexity, and inspection accountability.
The career narrative
Keisha Daniels began her career in chemistry and pharmaceutical manufacturing — working inside the science before moving into quality assurance leadership. That foundation matters because quality problems rarely arrive cleanly, and the ability to read a process, a record, and a regulatory expectation simultaneously is not something that can be acquired from the outside.
Her career spans sterile compounding operations, glass primary packaging for drug delivery systems, autologous cell therapy manufacturing, FDA-regulated biologics drug substance and drug product operations, and medical device quality systems — across roles from QA Supervisor to Senior Director.
Along the way, she has built and led quality teams, managed enterprise quality platform implementations across eQMS, DMS, and LMS environments and multiple sites, and prepared regulated sites for pre-approval inspection readiness across three continents. The AI capability at Bayou Vantage is grounded in that same foundation. It is not layered on top of the quality practice — it grows from it.
Credentials & Certifications
Education
B.S., Chemistry — Dillard University
Professional Certifications
The Risk Translator
She translates regulatory expectations, operational constraints, and compliance consequences into systems and strategies that quality organizations can actually defend. That translation is the work.
Capability span
The Bayou Vantage point of view starts with the science and the operating floor. Keisha Daniels worked as a chemist and in pharmaceutical QA before moving into quality leadership — which means process understanding, documentation discipline, and manufacturing consequence are built into the analytical foundation, not added later.
Her leadership background spans Quality Assurance, Quality Systems, and Quality Compliance across FDA-regulated environments governed by 21 CFR Parts 210 and 211, ICH Q10, and ISO 13485. That span creates a systems view — the ability to see how a quality decision at the process level becomes a regulatory consequence at the inspection level.
Bayou Vantage reflects leadership experience across global biologics manufacturers, specialty pharma CDMOs, medical device organizations, and multi-site operations spanning the U.S., Canada, the U.K., and Australia. That breadth means the advisory perspective scales — from a single-site readiness engagement to a complex multi-site quality system architecture.
Operating principles
Where Bayou Vantage is strongest
Why clients hire Bayou Vantage
Whether the challenge is inspection preparation, quality system architecture, platform implementation, or AI governance, Bayou Vantage engages with the specific issue rather than the general category.
